marijuana stocks

Form 10-K/A for ALTERNATIVE FUELS AMERICAS, INC.


16-Apr-2015

Annual Report

ITEM 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.We had $74,527 in revenue for the years ended December 31, 2014 and no revenue for the year ending 2013. Accordingly, management believes the most informative discussion is to present expenses and comment thereon.

                                                2014                       2013
Operating expenses:
Selling, general and administrative   $ 1,073,729        82.3 %   $ 281,548        95.0 %
Salaries                                   18,826        17.7 %                     5.0 %
Total operating expenses              $ 1,092,555       100.0 %   $ 281,548       100.0 %

Year ended December 31, 2014 compared to year ended December 31, 2013.

Total operating expenses increased approximately $811,007 in 2014 as compared to 2013. As noted elsewhere, we have been operating at extremely low levels of liquidity since April 2011. This affected both our ability to raise capital and also necessitated close attention to expenses. Our increase in expenses is related to the opening of our retail location.

Selling, general and administrative expenses

Selling, general and administrative expenses increased approximately $785,519 in 2014 compared to 2013. The primary components of the increase result from a substantial increase in both the number of consultants and management professionals as well as their fees.

Table of Contents 16
Interest expense

The increase in interest expense is the result of increased debt principal and interest in 2014 compared to 2013.

Liquidity and Capital Resources

Since January 2014, the Company has raised a total of $900,000, in a series of private placements of debt and equity securities. Management recognizes the Company’s current financial difficulties that, at December 31, 2014, include a working capital deficiency of $625,287 and limited cash. However, management believes that its Plan of Operations is strong. This plan recognizes the Company’s need to generate working capital to successfully develop its operations towards the goal of successfully operating in the legal recreational and medical marijuana sectors.

However, we may not be successful in raising additional capital, and assuming that we raise additional funds, the Company may not achieve profitability or positive cash flow. If we are not able to timely and successfully raise additional capital and/or achieve profitability or positive cash flow, our business, financial condition, cash flows and results of operations may be materially and adversely affected.

Critical Accounting Estimates

The following are deemed to be the most significant accounting estimates affecting us and our results of operations:

Fair value of financial instruments

The Company follows the provisions of ASC 820. This Topic defines fair value, establishes a measurement framework and expands disclosures about fair value measurements. We apply these provisions to estimate the fair value of our financial instruments including cash, accounts payable and accrued expenses, and notes payable.

Income Taxes

The Company accounts for income taxes in accordance with ASC 740, Accounting for Income Taxes, as clarified by ASC 740-10, Accounting for Uncertainty in Income Taxes. Our deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax basis of assets and liabilities given the provisions of enacted tax laws. Deferred income tax provisions and benefits are based on changes to the assets or liabilities from year to year. In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in which the Company operates, estimates of future taxable income, and available tax planning strategies. If tax regulations, operating results or the ability to implement tax-planning strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the “more likely than not” criteria of ASC 740.

ASC 740-10 requires that the Company recognize the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the “more-likely-than-not” threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.

Recently Issued Accounting Pronouncements

There are no recent accounting pronouncements issued by the Financial Accounting Standards Board (“FASB”), the American Institute of Certified Public Accountants (“AICPA”), and the Securities and Exchange Commission (“SEC”) believed by management to have a material impact on the Company’s present or future financial statements.

Table of Contents 17
Off-Balance Sheet Arrangements

There are no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$MCIG Announces New Investor Analyst Research Report

mCig Announces New Investor Analyst Research Report  mCig, Inc. ( OTCQB :…

Village Farms International (VFF) Reports Strong Second Quarter 2019 Results

Village Farms International Reports Strong Second Quarter 2019 Results – Canadian Cannabis…

American Green, Inc. (ERBB) Launches Motion Picture Company

American Green Launches Motion Picture Company American Green, Inc. (ERBB:OTC) is pleased to…

Cannabis Science, Inc. (CBIS) Appoints Dr. Jermane Bond, Noted Research Scientist, to Its Scientific Advisory Board

Cannabis Science, Inc. Appoints Dr. Jermane Bond, Noted Research Scientist, to Its…